چاپ مقاله اساتید دانشکده داروسازی در مجلات معتبر

اخیرا مقالات زیر توسط آقای دکتر جعفری و همکارانشان در مجلات معتبر به چاپ رسیده است . به ایشان در چاپ این مقالات ارزشمند تبریک می گوییم .

1- Akhtari J, Rezayat SM, Teymouri M, Alavizadeh SH, Gheybi F, Badiee A, Jaafari MR. 2016 May 30,Targeting, biodistributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors. Int J Pharm., 505(1-2):89-95.IF:3.99

2- Teymouri M, Badiee A, Golmohammadzadeh S, Sadri K, Akhtari J, Mellat M, Nikpoor AR, Jaafari MR. 2016 Jun 27; Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity. Int J Pharm. 511(1):236-244. IF:3.99

3- Alavizadeh SH, Akhtari J, Badiee A, Golmohammadzadeh S, Jaafari MR. 2016 Mar, Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models. Expert Opin Drug Deliv. 13(3):325-36. doi: 10.1517/17425247.2016.1121987. IF:5.43

4- Moosavian SA, Abnous K, Badiee A, Jaafari MR. 2016 Mar 1; Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Colloids Surf B Biointerfaces. 139: 228-236. IF:3.90

5- Zahmatkeshan M, Gheybi F, Rezayat SM, Jaafari MR. 2016 Apr 30, Improved drug delivery and therapeutic efficacy of PEGylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model. Eur J Pharm Sci. 86:125-35. IF:3.77